Syschem (India) Limited

BSE:531173 Stock Report

Market Cap: ₹2.1b

Syschem (India) Past Earnings Performance

Past criteria checks 0/6

Syschem (India) has been growing earnings at an average annual rate of 44.5%, while the Pharmaceuticals industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 30.2% per year.

Key information

44.5%

Earnings growth rate

43.6%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate30.2%
Return on equity-0.9%
Net Margin-0.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Syschem (India) makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:531173 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242,959-5790
30 Jun 242,85412700
31 Mar 242,33528640
31 Dec 232,02434600
30 Sep 231,85553550
30 Jun 231,64555500
31 Mar 231,30645470
31 Dec 2296166460
30 Sep 2272535460
30 Jun 226245430
31 Mar 22657-17490
31 Dec 21667-68500
30 Sep 21758-74500
30 Jun 21823-67440
31 Mar 21744-56450
31 Dec 20742-35390
30 Sep 20717-35340
30 Jun 20811-23330
31 Mar 20881-19330
31 Dec 19954-18330
30 Sep 19900-1310
30 Jun 199503300
31 Mar 191,0978330
31 Dec 181,18021330
30 Sep 181,23921290
30 Jun 181,01213250
31 Mar 187663290
31 Dec 174542200
30 Sep 17321-11190
30 Jun 17214-13110
31 Mar 17135-1580
31 Dec 169-510
30 Sep 1610-2120
30 Jun 168-2000
31 Mar 1636-2230
31 Dec 1599-1930
30 Sep 15105-1450
30 Jun 15115-2860
31 Mar 15114-3970
31 Dec 14101-53130
30 Sep 14136-37150
30 Jun 14170-17130
31 Mar 141846200
31 Dec 131938290

Quality Earnings: 531173 is currently unprofitable.

Growing Profit Margin: 531173 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 531173 is unprofitable, but has reduced losses over the past 5 years at a rate of 44.5% per year.

Accelerating Growth: Unable to compare 531173's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 531173 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (20.4%).

Return on Equity

High ROE: 531173 has a negative Return on Equity (-0.95%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 03:16
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Syschem (India) Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution